27577957|t|Adenosine arrests breast cancer cell motility by A3 receptor stimulation
27577957|a|In neutrophils, adenosine triphosphate (ATP) release and autocrine purinergic signaling regulate coordinated cell motility during chemotaxis. Here, we studied whether similar mechanisms regulate the motility of breast cancer cells. While neutrophils and benign human mammary epithelial cells (HMEC) form a single leading edge, MDA-MB-231 breast cancer cells possess multiple leading edges enriched with A3 adenosine receptors. Compared to HMEC, MDA-MB-231 cells overexpress the ectonucleotidases ENPP1 and CD73, which convert extracellular ATP released by the cells to adenosine that stimulates A3 receptors and promotes cell migration with frequent directional changes. However, exogenous adenosine added to breast cancer cells or the A3 receptor agonist IB-MECA dose - dependently arrested cell motility by simultaneous stimulation of multiple leading edges, doubling cell surface areas and significantly reducing migration velocity by up to 75 %. We conclude that MDA-MB-231 cells, HMEC, and neutrophils differ in the purinergic signaling mechanisms that regulate their motility patterns and that the subcellular distribution of A3 adenosine receptors in MDA-MB-231 breast cancer cells contributes to dysfunctional cell motility. These findings imply that purinergic signaling mechanisms may be potential therapeutic targets to interfere with the motility of breast cancer cells in order to reduce the spread of cancer cells and the risk of metastasis.
27577957	0	9	Adenosine	T103	UMLS:C0001443
27577957	18	36	breast cancer cell	T017	UMLS:C1512505
27577957	37	45	motility	T038	UMLS:C0007608
27577957	49	60	A3 receptor	T103	UMLS:C0664494
27577957	76	87	neutrophils	T017	UMLS:C0027950
27577957	89	111	adenosine triphosphate	T103	UMLS:C0001480
27577957	113	116	ATP	T103	UMLS:C0001480
27577957	130	139	autocrine	T038	UMLS:C0596138
27577957	140	160	purinergic signaling	T038	UMLS:C3158762
27577957	161	169	regulate	T038	UMLS:C0678661
27577957	182	195	cell motility	T038	UMLS:C0007608
27577957	203	213	chemotaxis	T038	UMLS:C0008018
27577957	259	267	regulate	T038	UMLS:C0678661
27577957	272	280	motility	T038	UMLS:C1510470
27577957	284	303	breast cancer cells	T017	UMLS:C1512505
27577957	311	322	neutrophils	T017	UMLS:C0027950
27577957	334	347	human mammary	T017	UMLS:C0929301
27577957	348	364	epithelial cells	T017	UMLS:C0014597
27577957	366	370	HMEC	T017	UMLS:C0014597
27577957	386	398	leading edge	T017	UMLS:C1621433
27577957	400	410	MDA-MB-231	T038	UMLS:C3898556
27577957	411	430	breast cancer cells	T017	UMLS:C1512505
27577957	448	461	leading edges	T017	UMLS:C1621433
27577957	476	498	A3 adenosine receptors	T103	UMLS:C0664494
27577957	512	516	HMEC	T017	UMLS:C0014597
27577957	518	528	MDA-MB-231	T038	UMLS:C3898556
27577957	529	534	cells	T017	UMLS:C1512505
27577957	535	546	overexpress	T038	UMLS:C1514559
27577957	551	574	ectonucleotidases ENPP1	T103	UMLS:C0084070
27577957	579	583	CD73	T103	UMLS:C0000530
27577957	599	612	extracellular	T017	UMLS:C0521119
27577957	613	616	ATP	T103	UMLS:C0001480
27577957	633	638	cells	T017	UMLS:C0007634
27577957	642	651	adenosine	T103	UMLS:C0001443
27577957	668	680	A3 receptors	T103	UMLS:C0664494
27577957	694	708	cell migration	T038	UMLS:C1622501
27577957	723	734	directional	T038	UMLS:C2246452
27577957	763	772	adenosine	T103	UMLS:C0001443
27577957	782	801	breast cancer cells	T017	UMLS:C1512505
27577957	809	820	A3 receptor	T103	UMLS:C0664494
27577957	821	828	agonist	T103	UMLS:C2987634
27577957	829	836	IB-MECA	T103	UMLS:C0250131
27577957	865	878	cell motility	T038	UMLS:C0007608
27577957	919	932	leading edges	T017	UMLS:C1621433
27577957	943	955	cell surface	T017	UMLS:C0699040
27577957	956	961	areas	T082	UMLS:C0205146
27577957	989	998	migration	T038	UMLS:C1622501
27577957	1040	1050	MDA-MB-231	T038	UMLS:C3898556
27577957	1051	1056	cells	T017	UMLS:C1512505
27577957	1058	1062	HMEC	T017	UMLS:C0014597
27577957	1068	1079	neutrophils	T017	UMLS:C0027950
27577957	1094	1114	purinergic signaling	T038	UMLS:C3158765
27577957	1131	1139	regulate	T038	UMLS:C0678661
27577957	1146	1154	motility	T038	UMLS:C0007608
27577957	1155	1163	patterns	T082	UMLS:C0449774
27577957	1177	1188	subcellular	T017	UMLS:C1258076
27577957	1205	1227	A3 adenosine receptors	T103	UMLS:C0664494
27577957	1231	1241	MDA-MB-231	T038	UMLS:C3898556
27577957	1242	1261	breast cancer cells	T017	UMLS:C1512505
27577957	1291	1304	cell motility	T038	UMLS:C0007608
27577957	1332	1352	purinergic signaling	T038	UMLS:C3158765
27577957	1423	1431	motility	T038	UMLS:C0007608
27577957	1435	1454	breast cancer cells	T017	UMLS:C1512505
27577957	1488	1500	cancer cells	T017	UMLS:C0334227
27577957	1517	1527	metastasis	T038	UMLS:C4255448